What Protocols Should Clinics Follow When Using Nonablative Fractional Laser Devices To Treat Acne Scars And Surgical Scarring In Dark-Skinned Patients? Safe, Test-Based Settings For Fitzpatrick Iv–Vi

Clinics should use a conservative, test-based protocol for Fitzpatrick IV–VI skin: assess the scar and pigment risk first, reduce fractional treatment density and overlapping passes, calibrate energy to scar depth and device specifications, and provide strict post-treatment photoprotection. The goal is controlled dermal heating—not maximal thermal delivery—because excessive overlap increases epidermal heat accumulation and the risk of post-inflammatory hyperpigmentation (PIH).

In dark skin, lower coverage density, limited overlap, cautious energy selection, active cooling, and close follow-up are more important than pursuing aggressive single-session correction. Settings must be individualized to the device, scar type, skin response, and clinician’s training.

Establish Whether the Patient Is an Appropriate Candidate

Classify the scar before selecting settings

Nonablative fractional lasers are most useful for atrophic acne scars, including rolling and some boxcar scars, and for selected mature surgical scars with textural irregularity.

Rolling scars may respond particularly well when laser remodeling is combined with subcision, because subcision releases tethered fibrous bands while the laser stimulates dermal remodeling.

Identify pigment and scarring risks

Document Fitzpatrick skin type, prior PIH, melasma, recent tanning, active acne, dermatitis, infection, keloid tendency, and previous adverse reactions to lasers.

Active infection, uncontrolled inflammatory acne, recently tanned skin, and unstable pigmentary disease generally warrant postponement or additional specialist assessment.

Examine surgical scars carefully

The scar should be sufficiently healed before elective laser treatment. Avoid treating an undiagnosed, infected, dehisced, or actively inflamed scar.

Raised or potentially keloidal scars require a different management strategy; nonablative fractional resurfacing should not be assumed to be appropriate simply because the scar is surgical.

Prepare Dark Skin to Reduce PIH

Stabilize pigment before treatment

For patients with a strong PIH or melasma history, clinicians may consider a prescribed pigment-stabilizing regimen, such as hydroquinone, before treatment.

Hydroquinone and tretinoin are not universally appropriate or mandatory. They should be selected only after assessing contraindications, irritation risk, pregnancy status where relevant, and the patient’s tolerance.

Stop irritating products at the correct time

Retinoids, exfoliating acids, scrubs, and other potentially irritating products should be paused according to the device protocol and the patient’s skin condition.

A commonly used approach is to stop tretinoin approximately one to two weeks before treatment, but the exact interval should follow the treating clinician’s judgment and the manufacturer’s guidance.

Avoid recent ultraviolet exposure

Do not treat actively tanned or sunburned skin. Pre-treatment sun avoidance reduces baseline melanocyte activity and makes post-treatment pigment changes easier to recognize and manage.

Select Conservative Laser Parameters

Reduce microthermal zone density

The principal adjustment for Fitzpatrick IV–VI skin is to lower the percentage of treated coverage or microthermal zone density.

Conservative coverage—sometimes in the approximate range of 11%–14%, depending on the system—may be used as a starting point, but these figures are not universal prescriptions. Device software, spot geometry, pulse duration, and energy delivery differ substantially.

Limit overlapping passes

Multiple passes over the same area increase cumulative thermal exposure. Clinics should use fewer overlapping passes initially and avoid stacking pulses unless the device-specific protocol and the patient’s response clearly justify it.

A practical principle is to treat the scar adequately while leaving enough untreated skin between microthermal zones to dissipate heat.

Match energy to scar depth

Energy or fluence should be calibrated to the target scar and the device’s wavelength. Deeper, more fibrotic scars may require greater dermal energy than superficial texture changes, but higher energy does not automatically produce better results in dark skin.

Reported acne-scar protocols vary widely, including examples using several passes or fluences in the 12–15 J/cm² or 28–32 J/cm² range. These values should not be transferred between machines because they may represent different wavelengths, pulse formats, spot sizes, and measurement conventions.

Use a test spot when risk is high

A test spot is particularly valuable for patients with Fitzpatrick V–VI skin, a history of PIH, melasma, recent tanning, or uncertain tolerance.

Assess delayed erythema, edema, crusting, and pigment response before expanding treatment. A test spot does not eliminate risk, but it can expose an overly aggressive protocol before a full-face or large-scar treatment.

Protect the Epidermis During Treatment

Prepare the surface completely

Remove makeup, creams, oils, and topical medications from the treatment field. Residual products may alter optical transmission or contribute to uneven heating.

The skin should be clean, dry, and free of substances not specifically approved for use with the laser.

Confirm cooling and contact systems

Verify that chilled-air cooling or another active epidermal-protection system is functioning before firing.

Cooling should be used consistently and appropriately, while avoiding excessive cooling that compromises contact, obscures the treatment response, or causes cold injury.

Observe the immediate endpoint

Monitor erythema, edema, discomfort, and any unexpected epidermal whitening, blistering, or excessive thermal response.

The desired response is controlled fractional heating. Blistering, severe pain, erosions, or disproportionate swelling should prompt cessation, assessment, and appropriate medical management.

Build a Staged Treatment Course

Use multiple conservative sessions

Scar remodeling is progressive and depends on new collagen and matrix reorganization. A typical course may involve four to six sessions, commonly separated by approximately two to six weeks, although longer intervals may be appropriate when erythema, PIH, or irritation persists.

Some patients require additional sessions, and the final result may continue evolving for six to nine months after treatment.

Treat the scar type, not only the skin tone

Rolling scars may benefit from subcision before or alongside fractional laser treatment. Ice-pick scars may respond better to focal techniques rather than broad fractional resurfacing alone.

Surgical scars may require a combination of laser remodeling, silicone-based scar care, intralesional treatment, or surgical revision depending on whether the dominant problem is texture, color, hypertrophy, or tethering.

Avoid treating too frequently

The skin should return close to baseline before the next session. Persistent erythema, active dermatitis, acne flare, or post-treatment darkening indicates that treatment should be delayed and the protocol reassessed.

Provide Structured Aftercare

Use gentle, non-irritating care

After nonablative fractional treatment, use a gentle cleanser and a bland, non-comedogenic moisturizer as needed.

Petrolatum-based occlusion is not automatically contraindicated in all laser procedures, but heavily occlusive products may aggravate acne-prone patients. The aftercare plan should reflect whether the skin is intact and whether the patient is prone to follicular occlusion or acne flares.

Make photoprotection mandatory

Use daily broad-spectrum SPF 30 or higher, along with shade and physical sun protection. Reapplication is important, particularly during outdoor exposure.

For patients with PIH or melasma risk, a tinted sunscreen containing iron oxides may provide additional visible-light protection, where appropriate.

Manage PIH early

New or worsening pigmentation should be documented and treated promptly rather than ignored. A clinician may restart or prescribe a pigment-modulating agent after the skin barrier has recovered.

Do not apply irritating bleaching agents, retinoids, or acids to freshly inflamed skin without medical direction.

Understanding the Trade-offs

Lower settings may require more sessions

Reducing density and overlap lowers the risk of PIH but may produce slower visible improvement. This is an acceptable trade-off because scar remodeling is cumulative and delayed.

More passes are not automatically better

Repeated passes can increase thermal accumulation without producing proportional collagen remodeling. In dark skin, the risk-benefit balance generally favors controlled coverage over aggressive stacking.

Device settings cannot be copied directly

A numerical setting from one 1,540 nm or 1,550 nm system may not be equivalent to the same number on another device. Energy, density, pulse duration, spot arrangement, cooling, and software algorithms all affect tissue exposure.

Pigment change is not the only complication

Clinics should also counsel patients about prolonged erythema, edema, acne or milia flares, infection, textural irregularity, burns, and—less commonly—paradoxical scarring or worsening pigmentary disease.

Informed consent should explain that improvement is gradual and may be incomplete, especially for deep ice-pick scars or substantial surgical-scar contracture.

How to Apply This to Clinical Practice

A safe protocol should be documented for each patient rather than reduced to a fixed fluence or pass count.

If your primary focus is PIH prevention: Use conservative density, minimal overlap, strict ultraviolet avoidance, active cooling, and a test spot before full treatment.
If your primary focus is atrophic acne scars: Classify the scar subtype, consider subcision for tethered rolling scars, and use a staged course rather than one aggressive session.
If your primary focus is surgical-scar texture: Treat only after complete healing and assess whether the scar is atrophic, hypertrophic, tethered, inflamed, or keloidal before choosing fractional laser.
If your primary focus is rapid visible improvement: Explain that lower-risk treatment in dark skin usually requires multiple sessions and that collagen remodeling continues for months.
If your primary focus is operational safety: Follow the manufacturer’s protocol, use trained medical personnel, verify cooling and contact systems, document parameters, and monitor delayed pigment changes at follow-up.

For dark-skinned patients, the most reliable strategy is controlled, incremental remodeling with disciplined pigment prevention—not maximum energy in a single treatment.

Summary Table:

Key Protocol Step	Dark Skin (Fitzpatrick IV–VI)	Rationale
Patient Selection	Assess scar type, pigment risk, and healing status	Avoid complications and target appropriate scars
Pre-Treatment Pigment Stabilization	Consider hydroquinone/retinoid; stop irritants 1–2 weeks prior	Reduce PIH risk and inflammation
Test Spot	Perform for high-risk patients	Determine individual tolerance and response
Laser Parameters	Lower density (~11–14%), limit overlap, adjust energy to scar depth	Minimize epidermal heat and PIH
Intra-Procedure	Use active cooling; observe erythema/blistering	Protect epidermis
Treatment Course	Multiple sessions (4–6), spaced 2–6 weeks	Gradual remodeling with lower risk
Aftercare	Gentle care, strict sun protection, early PIH management	Prevent and treat pigment issues

BELIS offers professional nonablative fractional laser systems designed for safe, effective treatment of acne scars and surgical scars in all skin types, including Fitzpatrick IV–VI. Our advanced platforms feature customizable parameters, active cooling, and proven protocols. Contact our experts today to learn how our technology can enhance your clinic's outcomes and patient satisfaction. Get in touch for a personalized consultation.